4 ms·

Thanks. That seemed to contradict my reading, but then when I clicked into the BioCentury article he referenced, I saw this: > By Selina Koch, Executive Editor

Thanks. That seemed to contradict my reading, but then when I clicked into the BioCentury article he referenced, I saw this: > By Selina Koch, Executive Editor | Feb 27, 2020 | 7:56 PM EST > Editor's note: Updated on Mar 17, 2020 at 9:30 PM EDT March 17th again. I'd love to know what edit was made at 9:30 PM on the same day the HCQ announcement came out. The Wayback Machine didn't find anything.

jcranmer 6y ago
The original text by Derek Lowe is available at https://web.archive.org/web/20200311135536/https://blogs.sciencemag.org/pipeline/archives/2020/03/06/covid-19-small-molecule-therapies-reviewed https://web.archive.org/web/20200311135536/https://blogs.sci... And Derek Lowe's summary was unchanged in his edit: > My personal opinion is that I like the chances of this drug [remdesivir] more than anything else on this list, but it’s still unlikely to be a game-changer.
- tboyd47 6y ago
  I was talking about the BioCentury article, not his article. Anyway, thanks again for finding that, because it's a valid counterpoint.